Hypomagnesemia and Hypermagnesemia

  • Joel Michels Topf
  • Patrick T. Murray
magnesium hypomagnesemia hypermagnesemia electrolyte metabolism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sanders GT, Huijgen HJ, Sanders R. Magnesium in disease: A review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 1999;37:1011–1033.Google Scholar
  2. 2.
    Yu ASL. Disturbances of magnesium metabolism. In: Brenner BM, ed. The Kidney. Philadelphia: WB. Saunders Company, 2000:1055–1070.Google Scholar
  3. 3.
    Kulpmann WR, Gerlach M. Relationship between ionized and total magnesium in serum. Scand J Clin Lab Invest Suppl 1996;224:251–258.Google Scholar
  4. 4.
    Thienpont LM, Dewitte K, Stockl D. Serum complexed magnesium–a cautionary note on its estimation and its relevance for standardizing serum ionized magnesium. Clin Chem 1999;45:154–155.Google Scholar
  5. 5.
    Fiser RT, Torres AJ, Butch AW, Valentine JL. Ionized magnesium concentrations in critically ill children. Crit Care Med 1998;26:2048–2052.Google Scholar
  6. 6.
    Broner CW, Stidham GL, Westenkirchner DF, Tolley EA. Hypermagnesemia and hypocalcemia as predictors of high mortality in critically ill pediatric patients. Critical Care Medicine 1990;18:921–928.Google Scholar
  7. 7.
    Saha H, Harmoinen A, Karvonen AL, Mustonen J, Pasternack A. Serum ionized versus total magnesium in patients with intestinal or liver disease. Clin Chem Lab Med 1998;36:715–718.Google Scholar
  8. 8.
    Gullestad L, Dolva LO, Waage A, Falch D, Fagerthun H, Kjekshus J. Magnesium deficiency diagnosed by an intravenous loading test. Scandinavian Journal of Clinical &; Laboratory Investigation 1992;52:245–253.Google Scholar
  9. 9.
    Marier JR. Magnesium content of the food supply in the modern-day world. Magnesium 1986;5:1–8.Google Scholar
  10. 10.
    Graham LA, Caeser JJ, Burgen ASV. Gastrointestinal Absorption and Excretion of Mg28 in Man. Metabolism Clinical and Experimental 1960;9(7):646–659.Google Scholar
  11. 11.
    Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol 1989;256:F197–210.Google Scholar
  12. 12.
    Murayama Y, Morel F, Le Grimellec C. Phosphate, calcium and magnesium transfers in proximal tubules and loops of Henle, as measured by single nephron micropuncture experimentsin the rat. Pfluegers Arch 1972;333:1–16.Google Scholar
  13. 13.
    Quamme GA. Renal magnesium handling: New insights in understanding old problems. (Review, 171 refs). Kidney International 1997;52:1180–1195.Google Scholar
  14. 14.
    Shafik IM, Quamme GA. Early adaptation of renal magnesium reabsorption in response to magnesium restriction. Am J Physiol 1989;257:F974–F977.Google Scholar
  15. 15.
    Shils ME. Experimental human magnesium depletion. Medicine 1969;48:61–85.Google Scholar
  16. 16.
    Martin BJ, Black J, McLelland AS. Hypomagnesaemia in elderly hospital admissions: A study of clinical significance. Quarterly Journal of Medicine 1991;78:177–184.Google Scholar
  17. 17.
    Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia: Requested vs routine. JAMA 1990;263:3063–3064.Google Scholar
  18. 18.
    Ryzen E, Wagers PW, Singer FR, Rude RK. Magnesium deficiency in a medical ICU population. Critical Care Medicine 1985;13:19–21.Google Scholar
  19. 19.
    Hebert P, Mehta N, Wang J, Hindmarsh T, Jones G, Cardinal P. Functional magnesium deficiency in critically ill patients identified using a magnesium-loading test. Critical Care Medicine 1997;25:749–755.Google Scholar
  20. 20.
    Rubeiz GJ, Thill-Baharozian M, Hardie D, Carlson RW. Association of hypomagnesemia and mortality in acutely ill medical patients. (see comments). Critical Care Medicine 1993;21:203–209.Google Scholar
  21. 21.
    Hermans C, Lefebvre C, Devogelaer JP, Lambert M. Hypocalcaemia and chronic alcohol intoxication: Transient hypoparathyroidism secondary to magnesium deficiency. (Review, 31 refs). Clinical Rheumatology 1996;15:193–196.Google Scholar
  22. 22.
    Lim P, Jacob E. Tissue Magnesium level in Chronic Diarrhea. J Lab Clin Invest 1972;80 number 3:313–321.Google Scholar
  23. 23.
    Davis BB, Preuss HG, Murdaugh HVJ. Hypomagnesemia following the diuresis of post-renal obstruction and renal transplant. Nephron 1975;14:275–280.Google Scholar
  24. 24.
    Kingston ME, Al-Siba'i MB, Skooge WC. Clinical manifestations of hypomagnesemia. Critical Care Medicine 1986;14:950–954.Google Scholar
  25. 25.
    Brucato A, Bonati M, Gaspari F, Colussi G, Giachetti M, Zoppi F, Ruggerone ML. Tetany and rhabdomyolysis due to surreptitious furosemide—importance of magnesium supplementation. Journal of Toxicology-Clinical Toxicology 1993;31:341–344.Google Scholar
  26. 26.
    Al-Tweigeri T, Magliocco AM, DeCoteau JF. Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: Case report and review of literature. (Review, 35 refs). Gynecol Oncol 1999;72:120–122.Google Scholar
  27. 27.
    Vlasveld LT, Cornelissen JJ, Dellemijn PL, Joosse MV, van dBMJ. Cortical blindness during treatment with cyclosporin]. (Review, 31 refs) [Dutch]. Nederlands Tijdschrift voor Geneeskunde 1994;138:2057–2061.Google Scholar
  28. 28.
    Kelepouris E, Kasama R, Agus ZS. Effects of intracellular magnesium on calcium, potassium and chloride channels. (Review, 29 refs). Mineral and Electrolyte Metabolism 1993;19:277–281.Google Scholar
  29. 29.
    Dickerson RN, Brown RO. Hypomagnesemia in hospitalized patients receiving nutritional support. Heart and Lung 1985;14:561–569.Google Scholar
  30. 30.
    White RE, Hartzell HC. Magnesium ions in cardiac function. Regulator of ion channels and second messengers. Biochem Pharmacol 1989;38:859–867.Google Scholar
  31. 31.
    Al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: Pathophysiologic and clinical overview. (see comments). (Review, 150 refs). Am J Kidney Dis 1994;24:737–752.Google Scholar
  32. 32.
    Zuccala G, Pahor M, Lattanzio F, Vagnoni S, Rodola F, De SP, Cittadini A, Cocchi A, Bernabei R. Detection of arrhythmogenic cellular magnesium depletion in hip surgery patients. BJA: British Journal of Anaesthesia 1997;79:776–781.Google Scholar
  33. 33.
    Ramee SR, White CJ, Svirarich JT, Watson TD, Fox RF. Torsades de pointes and magnesium deficiency. Am Heart J 1985;109:164–167.Google Scholar
  34. 34.
    Young IS, Goh EM, McKillop UH, Stanford CF, Nicholls DP, Trimble ER. Magnesium status and digoxin toxicity. British Journal of Clinical Pharmacology 1991;32:717–721.Google Scholar
  35. 35.
    Lichodziejewska B, KloS J, Rezler J, Grudzka K, Dluzniewska M, Budaj A, Ceremuzynski L. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. (see comments). Am J Cardiol 1997;79:768–772.Google Scholar
  36. 36.
    Nadler JL, Malayan S, Luong H, Shaw S, Natarajan RD, Rude RK. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. (see comments). Diabetes Care 1992;15:835–841.Google Scholar
  37. 37.
    Salem M, Kasinski N, Munoz R, Chernow B. Progressive magnesium deficiency increases mortality from endotoxin challenge: Protective effects of acute magnesium replacement therapy. Critical Care Medicine 1995;23:108–118.Google Scholar
  38. 38.
    Trunkey D, Carpenter MA, Holcroft J. Ionized calcium and magnesium: The effect of septic shock in the baboon. Journal of Trauma-Injury Infection &; Critical Care 1978;18:166–172.Google Scholar
  39. 39.
    Caddell JL, Goddard DR. Studies in protein-calorie malnutriton. I. Chemical evidence for magnesium deficiency. N Engl J Med 1967;276:533–535.Google Scholar
  40. 40.
    De MS, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E. Renal tubular dysfunction in chronic alcohol abuse—effects of abstinence. N Engl J Med 1993;329:1927–1934.Google Scholar
  41. 41.
    Rivlin RS. Magnesium deficiency and alcohol intake: Mechanisms, clinical significance and possible relation to cancer development (a review). (Review, 48 refs). J Am Coll Nutr 1994;13:416–423.Google Scholar
  42. 42.
    Nielsen JA, Thaysen EH. Acute and chronic magnesium deficiency following extensive small gut resection. Scandinavian Journal of Gastroenterology 1971;6:663–666.Google Scholar
  43. 43.
    Hessov I, Hasselblad C, Fasth S, Hulten L. Magnesium deficiency after ileal resections for Crohn's disease. Scandinavian Journal of Gastroenterology 1983;18:643–649.Google Scholar
  44. 44.
    Kellaway G, Ewen K. Magnesium deficiency complicating prolonged gastric suction. New Zealand Journal of Medicine 1962;62:137–142.Google Scholar
  45. 45.
    Cunningham JJ, Anbar RD, Crawford JD. Hypomagnesemia: A multifactorial complication of treatment of patients with severe burn trauma. Jpen: Journal of Parenteral and Enteral Nutrition 1987;11:364–367.Google Scholar
  46. 46.
    Berger MM, Rothen C, Cavadini C, Chiolero RL. Exudative mineral losses after serious burns: A clue to the alterations of magnesium and phosphate metabolism. American Journal of Clinical Nutrition 1997;65:1473–1481.Google Scholar
  47. 47.
    Kurtz I. Molecular pathogenesis of Bartter's and Gitelman's syndromes. Kidney Int 1998;54:1396–1410.Google Scholar
  48. 48.
    Bettinelli A, Bianchetti MG, Girardin E, Caringella A, Cecconi M, Appiani AC, Pavanello L, Gastaldi R, Isimbaldi C, Lama G et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992;120:38–43.Google Scholar
  49. 49.
    Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB. Gitelman's syndrome revisited: An evaluation of symptoms and health-related quality of life. Kidney Int 2001;59:710–717.Google Scholar
  50. 50.
    Bettinelli A, Bianchetti MG, Borella P, Volpini E, Metta MG, Basilico E, Selicorni A, Bargellini A, Grassi MR. Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with hypocalcuria (Gitelman's syndrome). Kidney Int 1995;47:547–551.Google Scholar
  51. 51.
    Levine DZ, Rionel N, De Rouffignac C. Flow Correlation influx of K, Ca, P, and Mg during continuous microperfusion of the loop of Henle in the rat. Kidney Int 1982;22:634–639.Google Scholar
  52. 52.
    Massry SG, Coburn JW, Chapman LW, Kleeman CR. The effect of long-term deoxycorticosterone acetate administration on the renal excretion of calcium and magnesium. J Lab Clin Invest 1968;71:212–219.Google Scholar
  53. 53.
    Ng LL, Garrido MC, Davies JE, Brochwicz-Lewinski MJ, Tan LB. Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride. British Journal of Clinical Pharmacology 1992;33:329–332.Google Scholar
  54. 54.
    Ralston MA, Murnane MR, Kelley RE, Altschuld RA, Unverferth DV, Leier CV. Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation 1989;80:573–580.Google Scholar
  55. 55.
    Barton CH, Vaziri ND, Martin DC, Choi S, Alikhani S. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med 1987;83:693–699.Google Scholar
  56. 56.
    A SR. Abnormal renal magnesium handling. Miner Electrolyte Metab 1993;19:232–240.Google Scholar
  57. 57.
    Lam M, Adelstein DJ. Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin. Am J Kidney Dis 1986; 8:164.Google Scholar
  58. 58.
    Buckley JE, Clark VL, Meyer TJ, Pealman NW. Hypomagnesemia after cisplatin combination chemotherapy. Arch Intern Med 1984;144:2347–2348.Google Scholar
  59. 59.
    Barton CH, Pahl M, Vaziri ND, Cesario T. Renal magnesium wasting associated with amphotericin B therapy. Am J Med 1984;77:471–474.Google Scholar
  60. 60.
    Bearden DT, Muncey LA. The effect of amiloride on amphotericin B-induced hypokalaemia. J Antimicrob Chemother 2001;48:109–111.Google Scholar
  61. 61.
    Wazny LD, Brophy DF. Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia. (see comments). (Review, 21 refs). Annals of Pharmacotherapy 2000;34:94–97.Google Scholar
  62. 62.
    Green CG, Doershuk CF, Stern RC. Symptomatic hypomagnesemia in cystic fibrosis. J Pediatr 1985;107:425–428.Google Scholar
  63. 63.
    Holben DH, Smith AM, Wilmott RW. Aminoglycosides lower serum magnesium concentrations in patients with cystic fibrosis: A retrospective study. Journal of the American Dietetic Association 1995;95:1152–1154.Google Scholar
  64. 64.
    June CH, Thompson CB, Kennedy MS, Nims J, Thomas ED. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 1985;39:620–624.Google Scholar
  65. 65.
    Arthur JM, Shamim S. Interaction of cyclosporine and FK506 with diuretics in transplant patients. Kidney International 2000;58:325–330.Google Scholar
  66. 66.
    Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control (see comments). Diabetologia 1992;35:77–79.Google Scholar
  67. 67.
    Gullestad L, Oystein DL, Birkeland K, Falch D, Fagertun H, Kjekshus J. Oral versus intravenous magnesium supplementation in patients with magnesium deficiency. Magnesium and Trace Elements 1991;10:11–16.Google Scholar
  68. 68.
    Leor J, Kloner RA. An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 1995;75:1292–1293.Google Scholar
  69. 69.
    Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 1995;92:2617–2621.Google Scholar
  70. 70.
    Herzog WR, Schlossberg ML, MacMurdy KS. Timing of magnesium therapy affects experimental infarct size. Circulation 1995;92:2622–2626.Google Scholar
  71. 71.
    Group ISIS-FISoISC. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669–697.Google Scholar
  72. 72.
    Costello RB, Moser-Veillon PB, DiBianco R. Magnesium supplementation in patients with congestive heart failure. [see comments.] J Am Coll Nutr 1997;16:22–31.Google Scholar
  73. 73.
    Ross JR, Dargan PI, Jones AL, Kostrzewski A. A case of hypomagnesaemia due to malabsorption, unresponsive to oral administration of magnesium glycerophosphate, but responsive to oral magnesium oxide supplementation. Gut 2001;48:857–858.Google Scholar
  74. 74.
    Clark B, Brown R. Unsuspected morbid hypermagnesemia in elderly patients. Am J Nephrol 1992;12:336–343.Google Scholar
  75. 75.
    Castelbaum A, Donofrio PD, Walker FO, Troost BT. Laxative abuse causing hypermagnesemia, quadriparesis, and neuromuscular junction defect. Neurology 1989;39:746–747.Google Scholar
  76. 76.
    Schelling JR. Fatal hypermagnesemia. Clinical Nephrology 2000;53:61–65.Google Scholar
  77. 77.
    Rizzo MA, Fisher M, Lock P. Hypermagnesemic pseudocoma. Arch Intern Med 1993;153:1130–1132.Google Scholar
  78. 78.
    Razavi B, Somers D. Hypermagnesemia-induced multiorgan failure. Am J Med 2000;108:686–687.Google Scholar
  79. 79.
    Weber C, Santiago R. Hypermagnesemia: A potential complication during treatment of theophylline intoxication with oral activated charcoal and magnesium-containing cathartics. Chest 1989;95:56–59.Google Scholar
  80. 80.
    Morisaki H, Yamamoto S, Morita Y, Kotake Y, Ochiai R, Takeda J. Hypermagnesemia-induced cardiopulmonary arrest before induction of anesthesia for emergency cesarean section. (Review, 13 refs). Journal of Clinical Anesthesia 2000;12:224–226.Google Scholar
  81. 81.
    Cruikshank DP, Pitkin RM, Reynolds WA, Williams GA, Hargis GK. Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fetal responses. American Journal of Obstetrics and Gynecology 1979;134:243–249.Google Scholar
  82. 82.
    Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984;310:1221–1225.Google Scholar
  83. 83.
    Gren J, Woolf A. Hypermagnesemia associated with catharsis in a salicylate-intoxicated patient with anorexia nervosa. Annals of Emergency Medicine 1989;18:2:200–203.Google Scholar
  84. 84.
    Eshleman SSH, Shaw LM. Massive theophylline overdose with atypical metabolic abnormalities. Clin Chem 1990;36:398–399.Google Scholar
  85. 85.
    Spital A, Greenwell R. Severe hyperkalemia durting magnesium sulfate therapy in two pregnant drug abusers. So Med J 1991;84:919–921.Google Scholar
  86. 86.
    Spies SL, Weiner CP, Gellhaus TM. The plasma renin-angiotensin system in preeclampsia: Effects of magnesium sulfate. Obstet Gynecol 1989;56:934–937.Google Scholar
  87. 87.
    AF, JW G. Angiotensin-converting enzyme activity in hypertensive subjects after magnesium sulfate theerapy. Am J Obstet Gynecol 1987;56:1375–1379.Google Scholar
  88. 88.
    Wacker WE, Parisi AF. Magnesium metabolism. (Review, 226 refs). N Engl J Med 1968;278:772–776 (concl.)Google Scholar
  89. 89.
    Woodard JA, Shannon M, Lacouture PG, Woolf A. Serum magnesium concentrations after repetitive magnesium cathartic administration. (Review, 23 refs). American Journal of Emergency Medicine 1990;8:297–300.Google Scholar
  90. 90.
    Birrer RB, Shallash AJ, Totten V. Hypermagnesemia-induced fatality following epsom salt gargles(1). J Emerg Med 2002;22:185–188.Google Scholar
  91. 91.
    McGuire JK, Kulkarni MS, Baden HP. Fatal hypermagnesemia in a child treated with megavitamin/megamineral therapy. Pediatrics 2000;105:18.Google Scholar
  92. 92.
    Ashton MR, Sutton D, Nielsen M. Severe magnesium toxicity after magnesium sulphate enema in a chronically constipated child. BMJ 1990;300:541.Google Scholar
  93. 93.
    Collinson PO, Burroughs AK. Severe hypermagnesaemia due to magnesium sulphate enemas in patients with hepatic coma. [erratum appears in Br Med J (Clin Res Ed) 1986 Nov 8;293(6556):1222.]. British Medical Journal Clinical Research Ed. 1986;293:1013–1014.Google Scholar
  94. 94.
    Outerbridge EW, Papageorgiou A, Stern L. Magnesium sulfate enema in a newborn. Fatal systemic magnesium absorption. JAMA 1973;224:1392–1393.Google Scholar
  95. 95.
    Porath A, Mosseri M, Harmon I, Ovsyshcher I, A K. Dead Sea water poisoning. Annals of Emergency Medicine 1989;18:2:187–191.Google Scholar
  96. 96.
    Meltzer SJ, Auer J. The antagonistic action of of calcium opon the inhibitory effect of magnesium. Am J Physiol 1908;21:400–419.Google Scholar
  97. 97.
    Galland L. Magnesium and inflammatory bowel disease. (Review, 34 refs). Magnesium 1988;7:78–83.Google Scholar
  98. 98.
    Lipner A. Symptomatic magnesium deficiency after small-intestinal bypass for obesity. BMJ 1977;1:148.Google Scholar
  99. 99.
    Papazachariou IM, Martinez-Isla A, Efthimiou E, Williamson RC, Girgis SI. Magnesium deficiency in patients with chronic pancreatitis identified by an intravenous loading test. Clinica Chimica Acta 2000;302:145–154.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Joel Michels Topf
    • 1
  • Patrick T. Murray
    • 2
  1. 1.Fellow in NephrologyUniversity of ChicagoChicagoUSA
  2. 2.Associate Professor of Clinical Medicine, Anesthesia & Critical Care Medicine, and Clinical PharmacologyUniversity of ChicagoChicagoUSA

Personalised recommendations